Genomic variants in polycystic ovary syndrome

Clinica Chimica Acta

Volumn 366, Issue 1-2, 2006, Pages 14-26

  Luque Ramírez, Manuel ^a,b   San Millán, José Luis ^a   Escobar Morreale, Héctor F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Diabetes; Hyperandrogenism; Inflammation; Insulin resistance; Molecular genetics; Obesity; Polycystic ovary syndrome

Indexed keywords

ADIPONECTIN; ARYLDIALKYLPHOSPHATASE 1; CALPAIN 10; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR;

ANDROGEN SYNTHESIS; CHRONIC INFLAMMATION; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERANDROGENISM; HYPOTHESIS; INSULIN RESISTANCE; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NONHUMAN; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; MODELS, BIOLOGICAL; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; VARIATION (GENETICS);

EID: 33644697354     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.10.017     Document Type: Review

References (181)

1. D.A. Ehrmann Polycystic ovary syndrome N Engl J Med 352 2005 1223 1236
2. A. Dunaif Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 1997 774 800
3. H.E. Cooper, W.N. Spellacy, K.A. Prem, and W.D. Cohen Hereditary factors in the Stein-Leventhal syndrome Am J Obstet Gynecol 100 1968 371 387
4. J.R. Givens Familial polycystic ovarian disease Endocrinol Metab Clin North Am 17 1988 771 783
5. R.S. Legro, R. Bentley-Lewis, D. Driscoll, S.C. Wang, and A. Dunaif Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity J Clin Endocrinol Metab 87 2002 2128 2133
6. B.O. Yildiz, H. Yarali, H. Oguz, and M. Bayraktar Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 2031 2036
7. R. Kaushal, N. Parchure, G. Bano, J.C. Kaski, and S.S. Nussey Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries Clin Endocrinol (Oxf) 60 2004 322 328
8. H.F. Escobar-Morreale, M. Luque-Ramirez, and J.L. San Millan The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome Endocr Rev 26 2005 251 282
9. J.M. Ordovas Cardiovascular disease genetics: a long and winding road Curr Opin Lipidol 14 2003 47 54
10. R.S. Cooper Gene-environment interactions and the etiology of common complex disease Ann Intern Med 139 2003 437 440
11. W.H. Frishman Biologic markers as predictors of cardiovascular disease Am J Med 104 1998 18S 27S
12. J.M. Fernandez-Real, and W. Ricart Insulin resistance and chronic cardiovascular inflammatory syndrome Endocr Rev 24 2003 278 301
13. C.C.J. Kelly, H. Lyall, J.R. Petrie, G.W. Gould, J.M.C. Connell, and N. Sattar Low grade chronic inflammation in women with polycystic ovarian syndrome J Clin Endocrinol Metab 86 2001 2453 2455
14. N. Boulman, Y. Levy, and R. Leiba Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease J Clin Endocrinol Metab 89 2004 2160 2165
15. J.P. Bastard, C. Jardel, and E. Bruckert Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss J Clin Endocrinol Metab 85 2000 3338 3342
16. H.F. Escobar-Morreale, R.M. Calvo, J. Sancho, and J.L. San Millán TNF-α and hyperandrogenism: a clinical, biochemical and molecular genetic study J Clin Endocrinol Metab 86 2001 3761 3767
17. G. Villuendas, J.L. San Millan, J. Sancho, and H.F. Escobar-Morreale The - 597 G/A and - 174 G/C polymorphisms in the promoter of the interleukin 6 gene (IL6) are associated with hyperandrogenism J Clin Endocrinol Metab 87 2002 1134 1141
18. B. Peral, J.L. San Millan, R. Castello, P. Moghetti, and H.F. Escobar-Morreale The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism J Clin Endocrinol Metab 87 2002 3977 3983
19. H.F. Escobar-Morreale, R.M. Calvo, G. Villuendas, J. Sancho, and J.L. San Millan Association of polymorphisms in the Interleukin 6 receptor complex with obesity and hyperandrogenism Obes Res 11 2003 987 996
20. H.F. Escobar-Morreale, G. Villuendas, J.I. Botella-Carretero, J. Sancho, and J.L. San Millan Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women Diabetologia 46 2003 625 633
21. M. Mohlig, J. Spranger, and M. Osterhoff The polycystic ovary syndrome per se is not associated with increased chronic inflammation Eur J Endocrinol 150 2004 525 532
22. J.L. Cresswell, D.J. Barker, C. Osmond, P. Egger, D.I. Phillips, and R.B. Fraser Fetal growth, length of gestation, and polycystic ovaries in adult life Lancet 350 1997 1131 1135
23. A. Gambineri, C. Pelusi, V. Vicennati, U. Pagotto, and R. Pasquali Obesity and the polycystic ovary syndrome Int J Obes Relat Metab Disord 26 2002 883 896
24. E. Carmina, T. Koyama, L. Chang, F.Z. Stanczyk, and R.A. Lobo Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167 1992 1807 1812
25. S.E. Kasim-Karakas, R.U. Almario, L. Gregory, R. Wong, H. Todd, and B.L. Lasley Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 615 620
26. M. Asunción, R.M. Calvo, J.L. San Millán, J. Sancho, S. Avila, and H.F. Escobar-Morreale A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain J Clin Endocrinol Metab 85 2000 2434 2438
27. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749
28. E. Diamanti-Kandarakis, C.R. Kouli, and A.T. Bergiele A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile J Clin Endocrinol Metab 84 1999 4006 4011
29. J.M. Fernandez-Real, and W. Ricart Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness Diabetologia 42 1999 1367 1374
30. S.B. Eaton, and M. Konner Paleolithic nutrition. A consideration of its nature and current implications N Engl J Med 312 1985 283 289
31. P. Parsons Success in mating: a coordinated approach to fitness through genotypes incorporating genes for stress resistance and heterozygous advantage under stress Behav Genet 27 1997 75 81
32. G.A. Burghen, J.R. Givens, and A.E. Kitabchi Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease J Clin Endocrinol Metab 50 1980 113 116
33. D. Shoupe, D.D. Kumar, and R.A. Lobo Insulin resistance in polycystic ovary syndrome Am J Obstet Gynecol 147 1983 588 592
34. R.J. Chang, R.M. Nakamura, H.L. Judd, and S.A. Kaplan Insulin resistance in nonobese patients with polycystic ovarian disease J Clin Endocrinol Metab 57 1983 356 359
35. A. Dunaif, K.R. Segal, W. Futterweit, and A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174
36. M. Rajkhowa, J. Bicknell, M. Jones, and R.N. Clayton Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia Fertil Steril 61 1994 605 612
37. E.Y. Adashi, A.J. Hsueh, and S.S. Yen Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells Endocrinology 108 1981 1441 1449
38. P. Moghetti, R. Castello, and C. Negri Insulin infusion amplifies 17-alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women - apparent relative impairment of 17,20-lyase activity J Clin Endocrinol Metab 81 1996 881 886
39. L. Poretsky, N.A. Cataldo, Z. Rosenwaks, and L.C. Giudice The insulin-related ovarian regulatory system in health and disease Endocr Rev 20 1999 535 582
40. J.E. Nestler, and D.J. Jakubowicz Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome N Engl J Med 335 1996 617 623
41. J.E. Nestler Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab 76 1993 273 274
42. J.E. Nestler Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications Semin Reprod Endocrinol 15 1997 111 122
43. R.S. Wilroy Jr., J.R. Givens, W.L. Wiser, S.A. Coleman, R.N. Andersen, and R.L. Summitt Hyperthecosis: an inheritable form of polycystic ovarian disease Birth Defects Orig Artic Ser 11 1975 81 85
44. J.R. Givens Ovarian hyperthecosis N Engl J Med 285 1971 691
45. S. Sam, R.S. Legro, R. Bentley-Lewis, and A. Dunaif Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 4797 4802
46. D.A. Ehrmann, J. Sturis, M.M. Byrne, T. Karrison, and R.L. Polonsky Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus J Clin Invest 96 1995 520 527
47. S. Colilla, N.J. Cox, and D.A. Ehrmann Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives J Clin Endocrinol Metab 86 2001 2027 2031
48. A.M. Lucassen, C. Julier, and J.P. Beressi Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR Nat Genet 4 1993 305 310
49. G.I. Bell, M.J. Selby, and W.J. Rutter The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences Nature 295 1982 31 35
50. D.M. Waterworth, S.T. Bennett, and N. Gharani Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome Lancet 349 1997 986 990
51. K. Michelmore, K. Ong, and S. Mason Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight Clin Endocrinol (Oxf) 55 2001 439 446
52. R.M. Calvo, D. Telleria, J. Sancho, J.L. San Millan, and H.F. Escobar-Morreale Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women Fertil Steril 77 2002 666 668
53. M. Vankova, J. Vrbikova, M. Hill, O. Cinek, and B. Bendlova Association of insulin gene VNTR polymorphism with polycystic ovary syndrome Ann N Y Acad Sci 967 2002 558 565
54. B.L. Powell, L. Haddad, and A. Bennett Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits J Clin Endocrinol Metab 90 2005 2988 2993
55. A. Dunaif, J. Xia, C.B. Book, E. Schenker, and Z. Tang Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome J Clin Invest 96 1995 801 810
56. M. Li, J.F. Youngren, and A. Dunaif Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators J Clin Endocrinol Metab 87 2002 4088 4093
57. G.S. Conway, C. Avey, and G. Rumsby The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome Hum Reprod 9 1994 1681 1683
58. S. Siegel, W. Futterweit, and T.F. Davies A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome Fertil Steril 78 2002 1240 1243
59. Z.J. Chen, Y.H. Shi, and Y.R. Zhao Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome Zhonghua Fu Chan Ke Za Zhi 39 2004 582 585
60. M. Urbanek, R.S. Legro, and D.A. Driscoll Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin Proc Natl Acad Sci U S A 96 1999 8573 8578
61. M. Urbanek, A. Woodroffe, K.G., Ewens, et al. Candidate gene region for polycystic ovary syndrome (PCOS) on chromosome 19p13.2. J Clin Endocrinol Metab 2005 [First published August 9 as doi:10.1210/jc.2005-0622].
62. S. Tucci, W. Futterweit, and E.S. Concepcion Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus J Clin Endocrinol Metab 86 2001 446 449
63. G. Villuendas, H.F. Escobar-Morreale, F. Tosi, J. Sancho, P. Moghetti, and J.L. San Millan Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome Fertil Steril 79 2003 219 220
64. L.R. Sorbara, Z. Tang, and A. Cama Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome Metabolism 43 1994 1568 1574
65. J.A. Talbot, E.J. Bicknell, M. Rajkhowa, A. Krook, S. Orahilly, and R.N. Clayton Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome J Clin Endocrinol Metab 81 1996 1979 1983
66. A. Corbould, Y.B. Kim, and J.F. Youngren Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling Am J Physiol Endocrinol Metab 288 2005 E1047 E1054
67. T. Sir-Petermann, F. Perez-Bravo, B. Angel, M. Maliqueo, M. Calvillan, and A. Palomino G972R polymorphism of IRS-1 in women with polycystic ovary syndrome Diabetologia 44 2001 1200 1201
68. S.A. El Mkadem, C. Lautier, and F. Macari Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome Diabetes 50 2001 2164 2168
69. D.A. Ehrmann, X. Tang, I. Yoshiuchi, N.J. Cox, and G.I. Bell Relationship of insulin receptor substrate-1 and-2 genotypes to phenotypic features of polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 4297 4300
70. G. Villuendas, J.I. Botella-Carretero, B. Roldan, J. Sancho, H.F. Escobar-Morreale, and J.L. San Millan Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls Hum Reprod 20 2005 3184 3191
71. J.L. San Millan, M. Corton, G. Villuendas, J. Sancho, B. Peral, and H.F. Escobar-Morreale Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity J Clin Endocrinol Metab 89 2004 2640 2646
72. S.F. Witchel, C. White, M.E. Siegel, and C.E. Aston Inconsistent effects of the proline12->alanine variant of the peroxisome proliferator-activated receptor-gamma2 gene on body mass index in children and adolescent girls Fertil Steril 76 2001 741 747
73. M. Hara, S.Y. Alcoser, A. Qaadir, K.K. Beiswenger, N.J. Cox, and D.A. Ehrmann Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene J Clin Endocrinol Metab 87 2002 772 775
74. S. Korhonen, S. Heinonen, and M. Hiltunen Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome Hum Reprod 18 2003 540 543
75. E.C. Tok, A. Aktas, D. Ertunc, E.M. Erdal, and S. Dilek Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype Hum Reprod 20 2005 1590 1595
76. S. Hahn, A. Fingerhut, and U. Khomtsiv The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome Clin Endocrinol (Oxf) 62 2005 573 579
77. D.A. Ehrmann, P.E. Schwarz, and M. Hara Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 1669 1673
78. H.F. Escobar-Morreale, B. Peral, G. Villuendas, R.M. Calvo, J. Sancho, and J.L. San Millan Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism Fertil Steril 77 2002 581 587
79. A. Gonzalez, E. Abril, and A. Roca Comment: CAPN10 alleles are associated with polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 3971 3976
80. A. Gonzalez, E. Abril, and A. Roca Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients J Clin Endocrinol Metab 88 2003 5529 5536
81. D. Panidis, A. Kourtis, and A. Kukuvitis Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione Hum Reprod 19 2004 1728 1733
82. N. Xita, I. Georgiou, and A. Chatzikyriakidou Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome Clin Chem 51 2005 416 423
83. F. Orio Jr., G. Matarese, and S. Di Biase Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 5887 5892
84. F. Orio Jr., S. Palomba, and T. Cascella Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 5110 5115
85. S.F. Witchel, R.N. Trivedi, and C. Kammerer Frequency of the T228A polymorphism in the SORBS1 gene in children with premature pubarche and in adolescent girls with hyperandrogenism Fertil Steril 80 2003 128 132
86. L. Haddad, J.C. Evans, and N. Gharani Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 2606 2610
87. A. Kumar, K.S. Woods, A.A. Bartolucci, and R. Azziz Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS) Clin Endocrinol (Oxf) 62 2005 644 649
88. A.H. Carey, K.L. Chan, F. Short, D. White, R. Williamson, and S. Franks Evidence for a single gene effect causing polycystic ovaries and male pattern baldness Clin Endocrinol (Oxf) 38 1993 653 658
89. M. Duskova, I. Cermakova, M. Hill, M. Vankova, P. Samalikova, and L. Starka What may be the markers of the male equivalent of polycystic ovary syndrome? Physiol Res 53 2004 287 294
90. R.S. Legro, A.R. Kunselman, L. Demers, S.C. Wang, R. Bentley-Lewis, and A. Dunaif Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 2134 2138
91. D.A. Ehrmann, R.B. Barnes, and R.L. Rosenfield Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion Endocr Rev 16 1995 322 353
92. A.M. Haavisto, K. Pettersson, M. Bergendahl, A. Virkamaki, and I. Huhtaniemi Occurrence and biological properties of a common genetic variant of luteinizing hormone J Clin Endocrinol Metab 80 1995 1257 1263
93. J.S. Tapanainen, R. Koivunen, and B.C. Fauser A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone J Clin Endocrinol Metab 84 1999 1711 1715
94. K. Elter, C.T. Erel, N. Cine, U. Ozbek, B. Hacihanefioglu, and E. Ertungealp Role of the mutations Trp8=>Arg and Ile15=>Thr of the human luteinizing hormone beta-subunit in women with polycystic ovary syndrome Fertil Steril 71 1999 425 430
95. K. Takahashi, K. Karino, and H. Kanasaki Influence of missense mutation and silent mutation of LHbeta-subunit gene in Japanese patients with ovulatory disorders Eur J Hum Genet 11 2003 402 408
96. W.X. Liao, A.C. Roy, C. Chan, S. Arulkumaran, and S.S. Ratnam A new molecular variant of luteinizing hormone associated with female infertility Fertil Steril 69 1998 102 106
97. Y. Tong, W.X. Liao, A.C. Roy, and S.C. Ng Association of AccI polymorphism in the follicle-stimulating hormone beta gene with polycystic ovary syndrome Fertil Steril 74 2000 1233 1236
98. Y. Tong, W.X. Liao, A.C. Roy, and S.C. Ng Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovarian failure and polycystic ovary syndrome Horm Metab Res 33 2001 221 226
99. V.L. Nelson, R.S. Legro, J.F. Strauss III, and J.M. McAllister Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries Mol Endocrinol 13 1999 946 957
100. V.L. Nelson, K.N. Qin, and R.L. Rosenfield The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome J Clin Endocrinol Metab 86 2001 5925 5933
101. J.K. Wickenheisser, P.G. Quinn, V.L. Nelson, R.S. Legro, J.F. Strauss III, and J.M. McAllister Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells J Clin Endocrinol Metab 85 2000 2304 2311
102. J.K. Wickenheisser, V.L. Nelson-Degrave, and J.M. McAllister Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 1720 1727
103. V.L. Nelson-Degrave, J.K. Wickenheisser, and K.L. Hendricks Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome Mol Endocrinol 19 2005 379 390
104. J.K. Wickenheisser, V.L. Nelson-DeGrave, P.G. Quinn, and J.M. McAllister Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1 Mol Endocrinol 18 2004 588 605
105. J.K. Wickenheisser, V.L. Nelson-Degrave, K.L. Hendricks, R.S. Legro, J.F. Strauss III, and J.M. McAllister Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 4858 4865
106. J.R. Wood, C.K. Ho, V.L. Nelson-Degrave, J.M. McAllister, and J.F. Strauss III The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling J Reprod Immunol 63 2004 51 60
107. L.H. Zhang, H. Rodriguez, S. Ohno, and W.L. Miller Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome Proc Natl Acad Sci U S A 92 1995 10619 10623
108. K.N. Qin, and R.L. Rosenfield Role of cytochrome P450c17 in polycystic ovary syndrome Mol Cell Endocrinol 145 1998 111 121
109. J.W. Martens, D.H. Geller, and W. Arlt Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome J Clin Endocrinol Metab 85 2000 4338 4346
110. A.H. Carey, D. Waterworth, and K. Patel Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17 Hum Mol Genet 3 1994 1873 1876
111. E. Diamanti-Kandarakis, M.I. Bartzis, and E.D. Zapanti Polymorphism T - >C (- 34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome Fertil Steril 71 1999 431 435
112. S. Franks The 17 alpha-hydroxylase/17,20 lyase gene (CYP17) and polycystic ovary syndrome Clin Endocrinol (Oxf) 46 1997 135 136
113. S. Franks, D. White, C. Gilling-Smith, A. Carey, D. Waterworth, and R. Williamson Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17 alpha Baillieres Clin Endocrinol Metab 10 1996 193 203
114. M. Liovic, J. Prezelj, A. Kocijancic, G. Majdic, and R. Komel CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation J Endocrinol Invest 20 1997 189 193
115. B. Marszalek, M. Lacinski, and N. Babych Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5′-UTR in patients with polycystic ovarian syndrome Gynecol Endocrinol 15 2001 123 128
116. K. Techatraisk, G.S. Conway, and G. Rumsby Frequency of a polymorphism in the regulatory region of the 17α-hydroxylase (CYP17) gene in hyperandrogenic states Clin Endocrinol 46 1997 131 134
117. S.F. Witchel, P.A. Lee, M. Suda-Hartman, R. Smith, and E.P. Hoffman 17 alpha-hydroxylase/17,20-lyase dysregulation is not caused by mutations in the coding regions of CYP17 J Pediatr Adolesc Gynecol 11 1998 133 137
118. N. Gharani, D.M. Waterworth, and S. Batty Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism Hum Mol Genet 6 1997 397 402
119. E. Diamanti-Kandarakis, M.I. Bartzis, A.T. Bergiele, T.C. Tsianateli, and C.R. Kouli Microsatellite polymorphism (tttta) at-528 base pairs of gene CYP11a influences hyperandrogenemia in patients with polycystic ovary syndrome Fertil Steril 73 2000 735 741
120. S. Daneshmand, S.R. Weitsman, A. Navab, A.J. Jakimiuk, and D.A. Magoffin Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters Fertil Steril 77 2002 274 280
121. J.L. San Millán, J. Sancho, R.M. Calvo, and H.F. Escobar-Morreale Role of the pentanucleotide (tttta)n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism Fertil Steril 75 2001 797 802
122. R.M. Calvo, M. Asuncion, D. Telleria, J. Sancho, J.L. San Millan, and H.F. Escobar-Morreale Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women J Clin Endocrinol Metab 86 2001 1746 1749
123. S.F. Siegel, D.N. Finegold, R. Lanes, and P.A. Lee ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism N Engl J Med 323 1990 849 854
124. T. Eldar Geva, A. Hurwitz, P. Vecsei, Z. Palti, A. Milwidsky, and A. Rosler Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia N Engl J Med 323 1990 855 863
125. Y.T. Chang, L. Zhang, and H.S. Alkaddour Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity Pediatr Res 37 1995 820 824
126. H.F. Escobar-Morreale, J.L. San Millán, R.R. Smith, J. Sancho, and S.F. Witchel The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations Fertil Steril 72 1999 629 638
127. G. Carbunaru, P. Prasad, and B. Scoccia The hormonal phenotype of nonclassic 3β-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency J Clin Endocrinol Metab 89 2004 783 794
128. N. Moghrabi, I.A. Hughes, A. Dunaif, and S. Andersson Deleterious missense mutations and silent polymorphism in the human 17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3) J Clin Endocrinol Metab 83 1998 2855 2860
129. J.W. Tomlinson, E.A. Walker, and I.J. Bujalska 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response Endocr Rev 25 2004 831 866
130. N. Draper, E.A. Walker, and I.J. Bujalska Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency Nat Genet 34 2003 434 439
131. J.L. San Millan, J.I. Botella-Carretero, and F. Alvarez-Blasco A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 4157 4162
132. P.C. White Genotypes at HSD11B1 and H6PD loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample J Clin Endocrinol Metab 90 2005 5880 5883
133. K.N. Hogeveen, P. Cousin, M. Pugeat, D. Dewailly, B. Soudan, and G.L. Hammond Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction J Clin Invest 109 2002 973 981
134. N. Xita, A. Tsatsoulis, A. Chatzikyriakidou, and I. Georgiou Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels J Clin Endocrinol Metab 88 2003 5976 5980
135. P. Cousin, P. Calemard-Michel, and L. Lejeune Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women J Clin Endocrinol Metab 89 2004 917 924
136. N. Xita, A. Tsatsoulis, I. Stavrou, and I. Georgiou Association of SHBG gene polymorphism with menarche Mol Hum Reprod 11 2005 459 462
137. A.J. Jakimiuk, S.R. Weitsman, and D.A. Magoffin 5alpha-reductase activity in women with polycystic ovary syndrome J Clin Endocrinol Metab 84 1999 2414 2418
138. M.A. Carson-Jurica, W.T. Schrader, and B.W. O'Malley Steroid receptor family: structure and functions Endocr Rev 11 1990 201 220
139. R.S. Legro, B. Shahbahrami, R.A. Lobo, and B.W. Kovacs Size polymorphisms of the androgen receptor among female Hispanics and correlation with androgenic characteristics Obstet Gynecol 83 1994 701 706
140. L. Ibanez, K.K. Ong, and N. Mongan Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism J Clin Endocrinol Metab 88 2003 3333 3338
141. A. Vottero, C.A. Stratakis, L. Ghizzoni, C.A. Longui, M. Karl, and G.P. Chrousos Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation J Clin Endocrinol Metab 84 1999 1091 1095
142. T. Hickey, A. Chandy, and R.J. Norman The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 161 165
143. R.M. Calvo, M. Asunción, J. Sancho, J.L. San Millán, and H.F. Escobar-Morreale The role of the CAG repeat polymorphism in the androgen-receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism J Clin Endocrinol Metab 85 2000 1735 1740
144. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
145. G. Howard, D.H. O'Leary, and D. Zaccaro Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators Circulation 93 1996 1809 1817
146. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
147. P.M. Ridker Role of inflammatory biomarkers in prediction of coronary heart disease Lancet 358 2001 946 948
148. G.S. Hotamisligil The role of TNFalpha and TNF receptors in obesity and insulin resistance J Intern Med 245 1999 621 625
149. R.S. Legro Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24 2003 302 312
150. F. Orio Jr., S. Palomba, and T. Cascella The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 2 5
151. L. Ibanez, A.M. Jaramillo, and A. de Zegher High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception Hum Reprod 20 2005 2457 2462
152. H.F. Escobar-Morreale, J.I. Botella-Carretero, G. Villuendas, J. Sancho, and J.L. San Millan Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity J Clin Endocrinol Metab 89 2004 806 811
153. G. Loverro, F. Lorusso, L. Mei, R. Depalo, G. Cormio, and L. Selvaggi The plasma homocysteine levels are increased in polycystic ovary syndrome Gynecol Obstet Invest 53 2002 157 162
154. H.F. Escobar-Morreale, M. Luque-Ramirez, F. Alvarez-Blasco, J.I. Botella-Carretero, J. Sancho, and J.L. San Millan Body iron stores are increased in overweight and obese women with polycystic ovary syndrome Diabetes Care 28 2005 2042 2044
155. G.S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M.F. White, and B.M. Spiegelman IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 271 1996 665 668
156. K.F. Roby, and P.F. Terranova Effects of tumor necrosis factor-alpha in
157. R.Z. Spaczynski, A. Arici, and A.J. Duleba Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells Biol Reprod 61 1999 993 998
158. A. Kaipia, S.Y. Chun, K. Eisenhauer, and A.J. Hsueh Tumor necrosis factor-alpha and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles Endocrinology 137 1996 4864 4870
159. F. Gonzalez, K. Thusu, E. Abdel-Rahman, A. Prabhala, M. Tomani, and P. Dandona Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome Metabolism 48 1999 437 441
160. C.R. Milner, J.E. Craig, N.D. Hussey, and R.J. Norman No association between the-308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries Mol Hum Reprod 5 1999 5 9
161. S. Korhonen, E.L. Romppanen, and M. Hiltunen Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor-alpha and polycystic ovary syndrome Gynecol Endocrinol 16 2002 271 274
162. K.T. Uysal, S.M. Wiesbrock, and G.S. Hotamisligil Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity Endocrinology 139 1998 4832 4838
163. F. Bazzoni, and B. Beutler The tumor necrosis factor ligand and receptor families N Engl J Med 334 1996 1717 1725
164. J.M. Fernandez-Real, M. Broch, and W. Ricart Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance Diabetes 47 1998 1757 1762
165. J.M. Fernandez-Real, A. Molina, and M. Broch Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy Diabetes 48 1999 1108 1112
166. D.A. Papanicolaou, and A.N. Vgontzas Interleukin-6: the endocrine cytokine J Clin Endocrinol Metab 85 2000 1331 1333
167. C. Haan, P.C. Heinrich, and I. Behrmann Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation Biochem J 361 2002 105 111
168. K. Walch, C. Grimm, R. Zeillinger, J.C. Huber, F. Nagele, and L.A. Hefler A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome Fertil Steril 81 2004 1638 1641
169. B.O. Yildiz, I.C. Haznedaroglu, S. Kirazli, and M. Bayraktar Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state J Clin Endocrinol Metab 87 2002 3871 3875
170. G. Tsanadis, G. Vartholomatos, and I. Korkontzelos Polycystic ovarian syndrome and thrombophilia Hum Reprod 17 2002 314 319
171. C.J. Glueck, S.G. Awadalla, H. Phillips, D. Cameron, P. Wang, and R.N. Fontaine Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage Fertil Steril 74 2000 394 397
172. B.E. Sobel Insulin resistance and thrombosis: a cardiologist's view Am J Cardiol 84 1999 37J 41J
173. T. Sakamoto, J. Woodcock-Mitchell, K. Marutsuka, J.J. Mitchell, B.E. Sobel, and S. Fujii TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes Am J Physiol 276 1999 C1391 C1397
174. E.M. Velazquez, S.G. Mendoza, P. Wang, and C.J. Glueck Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome Metabolism 46 1997 454 457
175. C.J. Glueck, P. Wang, R.N. Fontaine, L. Sieve-Smith, T. Tracy, and S.K. Moore Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome Metabolism 48 1999 1589 1595
176. D.A. Ehrmann, D.J. Schneider, and B.E. Sobel Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome J Clin Endocrinol Metab 82 1997 2108 2116
177. W.U. Atiomo, R. Fox, and J.E. Condon Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS) Clin Endocrinol (Oxf) 52 2000 487 492
178. L.J. McCormack, D.K. Nagi, and M.H. Stickland Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome Diabetologia 39 1996 1512 1518
179. E. Diamanti-Kandarakis, G. Palioniko, K. Alexandraki, A. Bergiele, T. Koutsouba, and M. Bartzis The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels Eur J Endocrinol 150 2004 793 798
180. K. Walch, C. Grimm, J.C. Huber, F. Nagele, A. Kolbus, and L.A. Hefler A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome Eur J Obstet Gynecol Reprod Biol 123 2005 77 81
181. E. Baker, S. Flora, J. Ferguson, and W. Evans Gonadotropin secretory dynamics in polycystic ovary syndrome Curr Opin Endocrinol Diabetes 9 2002 475 479